Shareholders in q.beyond have until 28 September to decide whether the company’s €3.78-per-share tender offer represents a fair price for their holdings. With the stock closing Friday at €3.48 — up 1.2 percent on the day — the offer carries a visible premium that management hopes will signal conviction in its own valuation. Yet the buyback lands at an awkward moment, arriving just weeks after the company slashed its full-year guidance and outlined a restructuring bill that will weigh on results through 2026.
The tender, which targets up to 2,491,589 shares for a total outlay of roughly €9.42 million, became legally possible only after the six-month waiting period following the company’s capital reduction in August had elapsed. The offer represents close to 10 percent of the share capital and is backed by a balance sheet that remains comfortably funded: net liquidity stood at €41 million as of 30 June, with an equity ratio of 70 percent.
A Lowered Bar for 2026
The timing of the buyback coincides with a sobering reset of expectations. q.beyond now guides to revenue of €176 million to €180 million for 2026, down from the €182 million to €190 million previously projected. The EBITDA outlook has been cut far more aggressively — to €3 million to €7 million from an earlier range of €10 million to €16 million — reflecting one-off transformation costs of €5 million to €6 million tied to an accelerated AI-driven overhaul.
Management also anticipates a negative group result and negative free cash flow for the year. The pain is meant to be temporary: from 2027, the restructuring is expected to generate annual savings of roughly €7 million, paving the way back to group profitability and sustainably positive free cash flow.
The second-quarter figures illustrate a business in transition rather than distress. Revenue came in at €43 million, down from €44.4 million in the prior-year quarter, while adjusted EBITDA slipped to €2.5 million from €2.7 million. The adjusted EBITDA margin held steady at 6 percent, and the group result remained at breakeven.
Should investors sell immediately? Or is it worth buying q.beyond?
The GITG Bet and a New Support Hub
Beyond the financial restructuring, q.beyond is repositioning its product portfolio for the post-IS-H era in healthcare. The acquisition of a 51 percent stake in GITG AG, announced roughly a month ago, gives the company access to a proprietary successor solution for S/4HANA in the health sector, internally designated GS-H. With legacy SAP offerings for hospitals reaching end-of-life, the move is designed to deepen existing client relationships while shifting the revenue mix toward higher-margin product sales rather than pure services.
Operationally, the company is also scaling its service infrastructure. A new site in Cluj, Romania, will take over AI-powered 24/7 customer support starting in the third quarter — a step aimed at cutting costs while maintaining service quality during the broader transformation.
Market Sentiment Remains Split
The share price has done little to resolve the tension between restructuring costs and future optionality. Over the past month, the stock has gained 3.6 percent, though it still sits 13 percent below its 52-week high of €4.00. Annualized volatility of 56 percent suggests investors remain divided on the equity’s prospects despite the tender offer’s apparent premium.
For now, the buyback stands as the clearest signal of how management values its own shares — a price meaningfully above where the market currently trades them. Whether that conviction proves justified will depend on the GITG integration and the pace of the broader cost program, milestones that will only become visible in the quarters ahead.
Ad
q.beyond Stock: Buy or Sell?! New q.beyond Analysis from September 5 delivers the answer:
The latest q.beyond figures speak for themselves: Urgent action needed for q.beyond investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 5.
q.beyond: Buy or sell? Read more here...
